Detalhe da pesquisa
1.
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Int J Cancer
; 152(2): 239-248, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082445
2.
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Int J Mol Sci
; 24(10)2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37239846
3.
Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation.
World J Biol Chem
; 13(4): 72-82, 2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36187719
4.
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Cancer Epidemiol Biomarkers Prev
; 31(9): 1863-1866, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700034
5.
Proinflammatory cytokines as potential risk factors of acute graft-versus-host disease and infectious complications after allogeneic hematopoietic stem cell transplantation.
Am J Blood Res
; 11(2): 149-156, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079628
6.
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.
Leuk Lymphoma
; 61(3): 699-706, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31746254
7.
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.
Leukemia
; 37(11): 2326-2329, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723249